Slynd birth con­trol drug­mak­er Ex­eltis hit with FDA let­ter over mis­lead­ing so­cial me­dia pro­mo­tion

A spon­sored so­cial me­dia post for Slynd birth con­trol is the lat­est ad of­fend­er in the eyes of the FDA’s pro­mo­tions watch­dog. The Of­fice of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA